CDT Equity(CDT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDT CDT Equity

休市中 09-04 16:00:00 EDT

0.6251

-0.1241

-16.56%

盘后0.6420

+0.0169+2.70%

19:59 EDT

最高0.7450	最低0.6120	成交量73.88万
今开0.7300	昨收0.7492	日振幅17.75%
总市值856.01万	流通市值854.27万	总股本1,369万
成交额52.58万	换手率5.41%	流通股本1,367万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDT","market":"US","secType":"STK","nameCN":"CDT Equity","latestPrice":0.6251,"timestamp":1788552000000,"preClose":0.7492,"halted":0,"volume":738820,"hourTrading":{"tag":"盘后","latestPrice":0.642,"preClose":0.6251,"latestTime":"19:59 EDT","volume":33610,"amount":21480.50515,"timestamp":1788566374508,"change":0.0169,"changeRate":0.027036,"amplitude":0.049432},"delay":0,"changeRate":-0.16564335290977042,"floatShares":13666099,"shares":13693900,"eps":-5400.367,"marketStatus":"休市中","change":-0.1241,"latestTime":"09-04 16:00:00 EDT","open":0.73,"high":0.745,"low":0.612,"amount":525755.5863932,"amplitude":0.177523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5400.367,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7492,"preHourTrading":{"tag":"盘前","latestPrice":0.7459,"preClose":0.7492,"latestTime":"09:23 EDT","volume":189574,"amount":144921.0007014,"timestamp":1788528232073,"change":-0.0033,"changeRate":-0.004405,"amplitude":0.186065},"postHourTrading":{"tag":"盘后","latestPrice":0.642,"preClose":0.6251,"latestTime":"19:59 EDT","volume":33610,"amount":21480.50515,"timestamp":1788566374508,"change":0.0169,"changeRate":0.027036,"amplitude":0.049432},"volumeRatio":0.6817410908478179},"requestUrl":"/m/hq/s/CDT","defaultTab":"news","newsList":[{"id":"1161327242","title":"CDT Equity 拟通过预融资权证增持Sarborg至22.7%，待8月28日股东批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1161327242","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161327242?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:31","pubTimestamp":1785760289,"startTime":"0","endTime":"0","summary":"CDT Equity 计划通过预融资权证将其在Sarborg的持股比例提高至22.7%。这一举措尚需在8月28日获得股东批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182906070","title":"CDT Equity与Sarborg投资者签署证券购买协议——2026年7月30日SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1182906070","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182906070?lang=zh_cn&edition=full","pubTime":"2026-08-01 05:28","pubTimestamp":1785533288,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件显示，CDT Equity已于2026年7月30日与Sarborg投资者正式签署了一项证券购买协议。这一重要协议的达成，标志着双方在资本市场领域的合作迈入了新的阶段。此次交易的具体条款与规模，均在向监管机构提交的官方文件中进行了详细说明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175697567","title":"CDT Equity公司于2026年5月15日签署股权信贷额度协议第二修正案 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1175697567","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175697567?lang=zh_cn&edition=full","pubTime":"2026-05-16 04:05","pubTimestamp":1778875519,"startTime":"0","endTime":"0","summary":"根据一份向美国证券交易委员会提交的最新文件，CDT Equity公司已于2026年5月15日，正式签署了其股权信贷额度协议的第二修正案。该修正案标志着公司与相关融资方就现有股权信贷安排的关键条款进行了修订与更新。此类协议通常涉及公司通过发行新股，从特定投资方处获得灵活信贷额度的融资机制。此次协议的修订细节，具体反映了CDT Equity在资本结构管理上的最新动向。文件显示，此次修订于5月15日生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1108343319","title":"CDT Equity通过Sarborg特征分析锁定罕见病机遇，加速对外授权战略布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1108343319","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108343319?lang=zh_cn&edition=full","pubTime":"2026-03-23 20:31","pubTimestamp":1774269084,"startTime":"0","endTime":"0","summary":"CDT Equity近日宣布，公司通过创新的Sarborg特征分析技术，成功识别出多个具有潜力的罕见病治疗方向。这一突破性进展将有力推动其对外授权战略的实施，为后续商业化合作奠定基础。\n该分析方法通过深度挖掘疾病分子特征，精准定位尚未被满足的临床需求。目前公司已启动与多家药企的初步接洽，计划将研究成果通过授权合作模式实现价值转化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122223427","title":"CDT Equity股东特别会议全票通过所有提案，公司迈入新发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1122223427","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122223427?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:31","pubTimestamp":1773837090,"startTime":"0","endTime":"0","summary":"CDT Equity近日召开特别股东大会，所有提交审议的提案均获股东高票通过。根据会议结果，CDT Equity将实施新的公司治理架构调整方案。分析人士指出，这为CDT Equity未来可能进行的并购重组或战略投资提供了灵活操作空间。CDT Equity此时通过系列改革方案，反映出其顺应行业趋势主动求变的战略意图。随着各项议案落地，CDT Equity预计将加速推进现有投资组合的优化调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618180714","title":"Cdt Equity Inc.盘中异动 早盘股价大跌5.04%报0.594美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618180714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618180714?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:42","pubTimestamp":1773236568,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时42分，Cdt Equity Inc.股票出现异动，股价急速下挫5.04%。截至发稿，该股报0.594美元/股，成交量4943股，换手率0.13%，振幅5.60%。Cdt Equity Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Kala Bio, Inc.、Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Acurx Pharmaceuticals, Inc.、Decoy Therapeutics Inc.较为活跃，换手率分别为900.74%、243.53%、39.94%，振幅较大的相关个股有Kala Bio, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Citius Pharmaceuticals, Inc.，振幅分别为25.18%、24.78%、22.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031121424997adce30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031121424997adce30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129953294","title":"CDT Equity公司修订购买协议 将最低股价下调至0.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129953294","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129953294?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:27","pubTimestamp":1773088033,"startTime":"0","endTime":"0","summary":"根据2026年3月3日向美国证券交易委员会提交的文件显示，CDT Equity公司已对其现有购买协议进行了重要修订。此次修订的核心内容是将协议中约定的最低股价从原先水平下调至每股0.60美元。\n这一调整反映了公司在当前市场环境下的战略考量。通过降低最低股价门槛，CDT Equity可能旨在为未来的融资活动创造更灵活的操作空间。此类价格调整通常被视为公司应对市场波动、优化资本结构的积极举措。\n值得注意的是，最低股价条款的修改往往与公司的长期发展规划密切相关。此次调整为0.60美元的新标准，将为CDT Equity后续的股权交易提供新的定价基准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518273780","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大跌5.42%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518273780?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Conduit Pharmaceuticals Inc.股票出现异动，股价急速跳水5.42%。截至发稿，该股报1.04美元/股，成交量22.6129万股，换手率4.80%，振幅6.21%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220029a26a2fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220029a26a2fd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTTW","CDTDA","BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517662391","title":"Conduit Pharmaceuticals Inc.盘中异动 大幅上涨5.59%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517662391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517662391?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271919,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，Conduit Pharmaceuticals Inc.股票出现波动，股价快速拉升5.59%。截至发稿，该股报1.13美元/股，成交量25.2957万股，换手率5.37%，振幅5.61%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223840abeb79cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223840abeb79cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTDA","CDTTW","BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910019","title":"Conduit Pharmaceuticals Inc.盘中异动 急速跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910019?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Conduit Pharmaceuticals Inc.股票出现异动，股价大幅跳水5.31%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDT","CDTTW","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634996","title":"Conduit Pharmaceuticals Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634996?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:39","pubTimestamp":1741012762,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时39分，Conduit Pharmaceuticals Inc.股票出现波动，股价大幅跳水5.00%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223922989a11a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223922989a11a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTTW","BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514750083","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大涨5.36%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514750083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514750083?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:31","pubTimestamp":1740756718,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时31分，Conduit Pharmaceuticals Inc.股票出现异动，股价急速上涨5.36%。截至发稿，该股报1.18美元/股，成交量19.9313万股，换手率4.23%，振幅7.14%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233158abe0f913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233158abe0f913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTTW","BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514868520","title":"Conduit Pharmaceuticals Inc.盘中异动 快速跳水5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514868520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514868520?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:23","pubTimestamp":1740586983,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时23分，Conduit Pharmaceuticals Inc.股票出现波动，股价大幅下跌5.74%。截至发稿，该股报1.15美元/股，成交量45.7722万股，换手率9.72%，振幅7.91%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270023039893c042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270023039893c042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","CDT","CDTTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513477830","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大跌5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513477830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513477830?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:14","pubTimestamp":1740410092,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时14分，Conduit Pharmaceuticals Inc.股票出现波动，股价急速下挫5.22%。截至发稿，该股报1.09美元/股，成交量29.8673万股，换手率8.20%，振幅6.96%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022423145298910078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022423145298910078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDT","BK4121","CDTTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296397","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296397?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:39","pubTimestamp":1740148759,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时39分，Conduit Pharmaceuticals Inc.股票出现异动，股价急速下挫5.03%。截至发稿，该股报1.13美元/股，成交量18.7284万股，换手率5.14%，振幅4.20%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223919988de00c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223919988de00c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDT","BK4121","CDTTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512632485","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大跌6.87%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512632485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512632485?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:48","pubTimestamp":1739976512,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时48分，Conduit Pharmaceuticals Inc.股票出现波动，股价大幅下挫6.87%。截至发稿，该股报1.22美元/股，成交量22.5721万股，换手率6.20%，振幅5.31%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192248329628d093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192248329628d093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","CDTTW","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166496","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘大幅下挫5.49%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166496?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Conduit Pharmaceuticals Inc.股票出现波动，股价大幅跳水5.49%。截至发稿，该股报1.55美元/股，成交量7.7708万股，换手率2.13%，振幅4.27%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822322296279732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822322296279732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTTW","CDT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511146525","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘快速下跌6.18%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511146525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511146525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:36","pubTimestamp":1739457411,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时36分，Conduit Pharmaceuticals Inc.股票出现波动，股价快速下跌6.18%。截至发稿，该股报1.67美元/股，成交量207.146万股，换手率56.87%，振幅6.67%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322365198842cc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322365198842cc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTTW","BK4121","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510071387","title":"Conduit Pharmaceuticals Inc.盘中异动 早盘股价大涨6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510071387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510071387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284302,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Conduit Pharmaceuticals Inc.股票出现异动，股价大幅上涨6.63%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc是一家临床阶段专业生物制药公司，成立的目的是促进生物制药公司尚未或尚未被优先考虑的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223142961f4794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223142961f4794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","CDTTW","CDT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863447","title":"Conduit Pharmaceuticals Inc.盘中异动 股价大跌5.26%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863447?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739197986,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Conduit Pharmaceuticals Inc.股票出现波动，股价快速跳水5.26%。截至发稿，该股报2.70美元/股，成交量388.619万股，换手率252.63%，振幅10.53%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc 是一家临床阶段的专业生物制药公司，其成立的目的是促进领先生物制药公司优先考虑的尚未或现在的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223306961e0053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223306961e0053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDT","BK4121","CDTTW"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cdtequity.com","stockEarnings":[{"period":"1week","weight":-0.6301},{"period":"1month","weight":-0.8259},{"period":"3month","weight":-0.9151},{"period":"6month","weight":-0.9963},{"period":"1year","weight":-0.9997},{"period":"ytd","weight":-0.998}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CDT Equity Inc.最初于2021年10月19日在特拉华州成立。该公司是一家数据驱动的药物开发企业，专注于通过科学创新和战略合作伙伴关系识别、优化和推进治疗资产。它利用人工智能、固体形态化学和资产来加速新疗法的开发，其研发管线涵盖自身免疫性疾病、男性不育症、肿瘤学、皮肤病学和动物健康领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.301375},{"month":2,"riseRate":0.25,"avgChangeRate":-0.223871},{"month":3,"riseRate":0.5,"avgChangeRate":-0.152567},{"month":4,"riseRate":0.2,"avgChangeRate":-0.201765},{"month":5,"riseRate":0.4,"avgChangeRate":-0.229084},{"month":6,"riseRate":0.4,"avgChangeRate":-0.249823},{"month":7,"riseRate":0.2,"avgChangeRate":-0.321208},{"month":8,"riseRate":0.2,"avgChangeRate":-0.230575},{"month":9,"riseRate":0.2,"avgChangeRate":-0.318204},{"month":10,"riseRate":0.25,"avgChangeRate":-0.350488},{"month":11,"riseRate":0.5,"avgChangeRate":0.368238},{"month":12,"riseRate":0.25,"avgChangeRate":-0.186115}],"exchange":"NASDAQ","name":"CDT Equity","nameEN":"CDT Equity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CDT Equity(CDT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CDT Equity(CDT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CDT Equity,CDT,CDT Equity股票,CDT Equity股票老虎,CDT Equity股票老虎国际,CDT Equity行情,CDT Equity股票行情,CDT Equity股价,CDT Equity股市,CDT Equity股票价格,CDT Equity股票交易,CDT Equity股票购买,CDT Equity股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CDT Equity(CDT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CDT Equity(CDT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}